Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > My gift to Newcamo, realstocky & marcjohnson
View:
Post by aussyspitz on Mar 05, 2020 4:59pm

My gift to Newcamo, realstocky & marcjohnson

No one besides pumpers care if CIBC bought today or not.  Volume of 2,483 shares shows little genuine interest in this stock. The chart on this stock looks absolutely horrendous and if it drops below 11.05 in the near term which in the absence of any solid announcement reflecting a real accomplishment is a strong possibility that would strongly indicate additional huge downside pressure.

Since neither Newcamo, realstocky or marcjohnson appear to lack the technical expertise to copy and paste the links to the article/s versus pasting the whole dam thing.

I have taken the liberty of preparing a nice standard cut and paste pumper response please consider this a gift.  Newcamo, realstocky, marcjohnon you have my explicit permission and are encouraged to use this in response to any post offering genuine critique of Liminal.

your friend Aussy   

<Cut & Paste Pumper Response>

Bashers want your shares. Buy now and hold for 1 to 2 years max. This stock will trade at $50 to $100 by end of the year

https://biotuesdays.com/2020/01/21/liminal-biosciences-making-headway-in-strategic-transformation/

https://www.cambridgenetwork.co.uk/news/liminal-biosciences-chooses-iconix-1-unity-campus-base-future-growth

<Cut & Paste Pumper Response>
Comment by charm7 on Mar 06, 2020 12:40pm
This post has been removed in accordance with Community Policy
Comment by GoBBs on Mar 06, 2020 2:07pm
Our lawyers will show the courts how shareholders were thrown under the bus by these people...
Comment by stockbuphoon on Mar 06, 2020 2:31pm
Charm7  I do believe that there was a ton of shorting going on and TV's dark web friends probably participated in some way. But, they may have simply capitalized on Laurin and Pritchard's (and apparently the board) mix of arrogance and ignorance. Who could not see that Ryplazim was 100% clinical functional and safe and realize that the only tricky thing to FDA approval was CMC? So, ...more  
Comment by aussyspitz on Mar 06, 2020 2:45pm
stockbuphoon you have my respect and your counterpoint is well taken I know you went for the rights offer so I do hope you at least break even. I agree that this is most definitely a high risk investment and yes there is a possibility it could ultimately pay handsomely. My issue with the pumpers on this board is that they totally ignore the risk and only pump the postives. For me personally the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities